Cancer cachexia therapeutics
Cancer cachexia therapeutics
癌症恶病质疗法
批准号：
nhmrc : 1117541
负责人：
A/Pr Hamsa Puthalakath
金额：
$42.65万
依托单位：
依托单位国家：
澳大利亚
项目类别：
Development Grants
财政年份：
2017
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2017-01-01 至 2018-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer cachexia therapeutics
-
批准号：nhmrc : GNT1117541
-
项目类别：Development Grants
-
资助金额：$62.67万
-
财政年份：2017
-
负责人：A/Pr Hamsa Puthalakath
-
依托单位：
Developing a new treatment method to prevent lymphopenia associated with sepsis
-
批准号：nhmrc : GNT1085328
-
项目类别：Project Grants
-
资助金额：$42.25万
-
财政年份：2015
-
负责人：A/Pr Hamsa Puthalakath
-
依托单位：
Developing a new treatment method to prevent lymphopenia associated with sepsis
-
批准号：nhmrc : 1085328
-
项目类别：Project Grants
-
资助金额：$29.07万
-
财政年份：2015
-
负责人：A/Pr Hamsa Puthalakath
-
依托单位：
DETERMINING THE ROLE OF ER STRESS INDUCED APOPTOSIS IN THYMIC NEGATIVE SELECTION
-
批准号：nhmrc : 487311
-
项目类别：NHMRC Project Grants
-
资助金额：$37.22万
-
财政年份：2008
-
负责人：A/Pr Hamsa Puthalakath
-
依托单位：
海外基金
